Concepedia

Publication | Closed Access

2749 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with recurrent or refractory ovarian cancer: A phase Ib trial reporting safety and clinical activity

DOI

11

Citations

0

References

2015

Year

ML Disis, M.R. Patel, S. Pant, E.P. Hamilton, A. Craig Lockhart, Karen Kelly, J. Thaddeus-Beck, M. Gordon, Glen J. Weiss, Samuel Ejadi,
European Journal of Cancer

No additional data available for this publication yet. Check back later!